Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022Business Wire • 05/02/22
Earnings Preview: Twist Bioscience (TWST) Q2 Earnings Expected to DeclineZacks Investment Research • 04/28/22
Twist Bioscience to Become Voting Member of Storage Networking Industry AssociationBusiness Wire • 04/21/22
Twist Bioscience Announces Promotions and Changes to Executive Leadership TeamBusiness Wire • 04/21/22
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022Business Wire • 04/18/22
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell TherapiesBusiness Wire • 04/07/22
Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated MinicapsulesBenzinga • 03/21/22
Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene's Stainless Steel CapsulesBusiness Wire • 03/21/22
Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene TherapyBusiness Wire • 03/09/22
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 02/15/22
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common StockBusiness Wire • 02/11/22
Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare ConferenceBusiness Wire • 02/10/22
C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer DetectionBusiness Wire • 02/08/22
Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, TherapeuticsBenzinga • 02/07/22
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral ToolsBusiness Wire • 02/07/22
Twist Bioscience's (TWST) CEO Emily Leproust on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/04/22